Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Exousia Bio (LMMY) Other Operating Expenses (2024 - 2025)

Lamy (LMMY) has disclosed Other Operating Expenses for 2 consecutive years, with $13471.0 as the latest value for Q4 2025.

  • Quarterly Other Operating Expenses changed N/A to $13471.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $48748.0 through Nov 2025, up 1426.48% year-over-year, with the annual reading at $3463.0 for FY2025, N/A changed from the prior year.
  • Other Operating Expenses hit $13471.0 in Q4 2025 for Lamy, down from $31814.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $31814.0 in Q3 2025 to a low of -$3675.0 in Q3 2024.